Physician

Theodore Rexford Addai, M.D.

According to 2025 Medicare claims, Theodore Addai, M.D. (NPI: 1912985185) practices cardiology in the Decatur, IL market, with the plurality of this provider's patient population coming from Macon, IL. This provider's primary affiliated billing organization is PRAIRIE CARDIOVASCULAR CONSULTANTS LTD (NPI: 1982714218; TIN: 371071858) and primary practice location at 62521-3810. Addai is affiliated with the IRCCO (ACO ID: A2619), HSHS ACO, L.L.C. (ACO ID: A2783), and SBL accountable care organization (ACO ID: A5147), participating under the MSSP model.

Addai's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 888 traditional Medicare patients, billed 2,409 HCPCS/CPT codes, and received $160,964 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 8,207 prescription claims across 715 beneficiaries totaling $1,837,305 in drug costs, led by Entresto (Sacubitril/Valsartan). Open Payments data shows 18 records totaling $394. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $242,271 to $1,837,305. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,476	4,189	$215,185
2016	1,756	4,788	$220,696
2017	1,780	5,002	$228,558
2018	1,966	5,201	$235,074
2019	1,980	5,392	$273,977
2020	1,370	4,046	$226,279
2021	1,073	3,362	$210,385
2022	1,039	3,157	$207,318
2023	980	2,875	$209,837
2024	888	2,409	$160,964

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	463	6,443	$242,271
2016	495	7,006	$303,603
2017	473	6,711	$351,006
2018	571	6,241	$396,695
2019	603	6,072	$404,708
2020	589	6,451	$489,446
2021	592	6,192	$649,946
2022	610	6,618	$1,035,313
2023	678	7,521	$1,406,069
2024	715	8,207	$1,837,305

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	187	234	$125
75574	Ct scan of blood vessels and grafts of heart with contrast	83	84	$89
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	249	261	$87
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	305	321	$53
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	219	248	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Entresto	Sacubitril/Valsartan	624	23,376	$484,340
Jardiance	Empagliflozin	601	22,409	$429,835
Eliquis	Apixaban	482	18,387	$353,135
Farxiga	Dapagliflozin Propanediol	171	5,866	$110,156
Xarelto	Rivaroxaban	75	4,170	$79,460

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$394	Merck Sharp & Dohme LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Theodore Rexford Addai, M.D.?

Tedicare shows public-source Medicare data for Theodore Rexford Addai, M.D. (NPI 1912985185), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Theodore Rexford Addai, M.D. have ACO affiliation data?

Theodore Rexford Addai, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619), HSHS ACO, L.L.C. (MSSP, ACO ID A2783), and SBL accountable care organization (MSSP, ACO ID A5147).

What billing organization is linked to Theodore Rexford Addai, M.D.?

Theodore Rexford Addai, M.D. is linked to PRAIRIE CARDIOVASCULAR CONSULTANTS LTD (billing NPI 1982714218) in the available physician profile data.

Does Theodore Rexford Addai, M.D. have Open Payments data?

Theodore Rexford Addai, M.D. has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.